Genopathy
Gene-Disorder Association · Article
Gene
ENO2
Enolase 2
Disorder
Glycogen Storage Disease Xiii
First reported 1971
Key publication · disorder Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints.Archives of disease in childhood · 1971
Manually curated
Association Review

In brief

The association between ENO2 (Enolase 2) and Glycogen Storage Disease Xiii is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 11
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
ENO2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Glycogen Storage Disease Xiii

The disorder

10 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

5 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Provenance

References & sources

6 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access